Optimization of the contrast dose and injection rates in whole-body MR angiography at 3.0T

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 5, 2009, Pages 1059-1067

  Waugh, Shelley A ^a   Ramkumar, P Guntur ^a   Gandy, Stephen J ^a   Nicholas, R Stephen ^a   Martin, Patricia ^a   Belch, Jill J F ^a   Struthers, Allan D ^a   Houston, J Graeme ^a  

^a NINEWELLS HOSPITAL   (United Kingdom)

Author keywords

Contrast optimization; Image quality; MR angiography; Whole body

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM;

ADULT; AGED; ANATOMY; ARTERY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INJECTION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIATION DOSE; SIGNAL NOISE RATIO; WHOLE BODY CT;

ADULT; AGED; ANGIOGRAPHY; ARTIFACTS; ATHEROSCLEROSIS; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; RISK; WHOLE BODY IMAGING;

EID: 70350445905     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21930     Document Type: Article

References (32)

1. Watchell K, Ibsen H, Olsen MH, et al. Prevalence of renal artery stenosis in patients with peripheral vascular disease and hypertension. J Hum Hypertens 1996;10:83-85. (Pubitemid 26101029)
2. Alexandrova NA, Gibson WC, Norris JW, Maggisano R. Carotid artery stenosis in peripheral vascular disease. J Vasc Surg 1996; 23:645-649. (Pubitemid 26131823)
3. Marek J, Mills JL, Harvich J, Cui H, Fujitani RM. Utility of routine carotid duplex screening in patients who have claudication. J Vasc Surg 1996;24:572-577. (Pubitemid 26346620)
4. Fenchel M, Requardt M, Tomaschko K, et al. Whole-body MR angiography using a novel 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn Reson Imaging 2005;21:596-603. (Pubitemid 40586759)
5. Fenchel M, Scheule AM, Stauder NI, et al. Atherosclerotic disease: whole-body cardiovascular imaging with MR system with 32 receiver channels and total-body surface coil technology-initial clinical results. Radiology 2006;238:280-291. (Pubitemid 43010606)
6. Lin J, Chen B, Wang JH, Zeng MS, Wang YX. Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases. Heart Vessels 2006;21:395-398.
7. Nael K, Ruehm SG, Michaely HJ, et al. Multistation whole-body high spatial resolution MR angiography using a 32-channel MR system. AJR Am J Roentgenol 2007;188:529-539. (Pubitemid 46167757)
8. Ruehm SG, Goehde SC, Goyen M. Whole body MR angiography screening. Int J Cardiovasc Imag 2004;30:587-591.
9. Seeger A, Kramer U, Fenchel M, et al. Comparison between a linear versus macrocyclic contrast agent for whole body MR angiography in a clinical routine setting. J Cardiovasc Magn Reson 2008;10:63-71.
10. Nael K, Fenchel M, Krishnam M, Laub G, Finn JP, Ruehm SG. High spatial resolution whole-body MR angiography with high acceleration parallel acquisition and 32-channel 3.0T unit: initial experience. Radiology 2007;242:865-872. (Pubitemid 46310101)
11. Du J, Korosec FR, Wu Y, Grist TM, Mistretta CA. Whole-body MR angiography using variable density sampling and dual-injection bolus-chase acquisition. Magn Reson Imaging 2008;26: 181-187.
12. Hansen T, Ahlström H, Johansson L. Whole-body screening of atherosclerosis with magnetic resonance angiography. Top Magn Reson Imaging 2007;18:329-337. (Pubitemid 350145113)
13. Knopp MV, Giesel FL, von Tengg-Kobligk H, et al. Contrast-enhanced MR angiography of the vasculature: intraindividual comparison of gadobenate dimeglumine with gadopentetate dimeglumine. J Magn Reson Imaging 2003;17:694-702. (Pubitemid 36665874)
14. Herborn CU, Goyen M, Quick HH, et al. Whole-body 3D MR angiography of patients with peripheral arterial occlusive disease. AJR Am J Roentgenol 2004;182:1427-1434. (Pubitemid 38668842)
15. Zhang H, Maki JH, Prince MR. 3D contrast enhanced MR angiography. J Magn Reson Imaging 2007;25:13-25.
16. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359-2362. (Pubitemid 44300951)
17. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243:148-157. (Pubitemid 46579705)
18. Grobner T. Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic sclerosis?Nephrol Dial Transplant 2006;21:1104-1108.
19. Wiginton CD, Kelly B, Oto A, et al. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis and gadolinium detection in tissue. AJR Am J Roentgenol 2008;190:1060-1068. (Pubitemid 351571526)
20. Krautmacher C, Willineck WA, Tschampa HJ, et al. Brain tumours: full and half-dose contrast-enhanced MR imaging at 3.0T compared with 1.5T-initial experience. Radiology 2005; 237:1014-1019. (Pubitemid 41636395)
21. Brown DG, Riederer SJ. Contrast-to-noise ratios in maximum intensity projection images. Magn Reson Med 1992;23: 130-137.
22. Hood MN, Ho VB, Foo TK, Marcos HB, Hess SL, Choyke PL. High resolution gadolinium-enhanced 3d MRA of the infrapopliteal arteries: lessons for improving bolus-chase peripheral MRA. Magn Reson Imaging 2002;20:543-549.
23. Herborn CU, Waleed A, Goyen M, Massing S, Ruehm SG, Debatin JF. Peripheral vasculature: whole body MR angiography with midfemoral venous compression-initial experience. Radiology 2004;230:872-878. (Pubitemid 38252889)
24. Pereles FS, Collins JD, Carr JC, et al. Accuracy of stepping-table lower extremity MR angiography with dual-level bolus timing and separate calf acquisition: hybrid peripheral MR angiography. Radiology 2006;183:283-290.
25. Zhang HL, Ho BY, Chao M, et al. Decreased venous contamination on 3D gadolinium enhance bolus chase peripheral MR angiography using thigh compression. Am J Roesntgenol 2004; 183:1041-1047. (Pubitemid 44185094)
26. Earls JP, Patel NH, Smith PA, DeSena S, Meissner MH. Gadolinium- enhanced three-dimensional MR angiography of the aorta and peripheral arteries: evaluation of a multistation examination using two gadopentetate dimeglumine infusions. AJR Am J Roentgenol 1998;171:599-604. (Pubitemid 28406112)
27. Prince MR. Gadolinium-enhanced MR aortography. Radiology 1994;191:155-164.
28. Ho KY, De Haan MW, Kessels AG, Kitslaar PJ, Van Engelshoven JM. Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography. Radiology 1998;206: 673-681. (Pubitemid 28128514)
29. O'Connell MJ, Murray JG. Value of subtraction technique in Gd- DTPA enhanced magnetic resonance angiography of the thoracic aorta. Clin Radiol 2001;56:545-549.
30. Schindera ST, Miller CM, Ho LM, DeLong DM, Merkle E. Magnetic resonance (MR) cholangiography. Quantitative and qualitative comparison of 3.0 Tesla with 1.5 Tesla. Invest Radiol 2007;42: 399-405.
31. Graham C, Winder RJ, Ellis PK, Kelly B. Magnetic resonance cholangiopancreatography- evaluation of image quality in breath-hold and non-breath-hold technique. Radiography 2004;10:195-199. (Pubitemid 38887672)
32. Yoshikawa T, Ohno Y, Motohara T, et al. Gadolinium-enhanced phase-contrast magnetic resonance portography. Magn Reson Med Sci 2005;4:165-174.